Seamus Mulligan insider trades

Open-market stock purchases and sales by Seamus Mulligan, Director at Jazz Pharmaceuticals plc, from SEC Form 4 filings since Mar 9, 2012.

Track record: 100% of 13 scored buys are up 5% or more since purchase, averaging +114%.

Recent trades

DateStockTradeValue
Aug 5, 2026JAZZ Jazz Pharmaceuticals plcBought (not open market)—
May 28, 2026JAZZ Jazz Pharmaceuticals plcBought (not open market)—

Companies traded

  • JAZZ Jazz Pharmaceuticals plc: 13 buys, 73 sales, last Aug 5, 2026

Get free alerts when Seamus Mulligan files a new trade →